Cargando…
Cytotoxic drugs in ocular lesions of Behçet's disease
Autores principales: | Davatchi, F, Shahram, F, Chams, H, Nadji, A, Jamshidi, AR, Chams, C, Akbarian, M, Gharibdoost, F, Sedigh, M, Sadeghi, B |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2003
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2833445/ http://dx.doi.org/10.1186/ar978 |
Ejemplares similares
-
Ophthalmic findings in Behcet׳s disease: Cases without apparent ocular signs
por: Chams, Hormoz, et al.
Publicado: (2015) -
Characteristics of Macular Edema in Behcet Disease after Intravitreal Bevacizumab Injection
por: Ghassemi, Fariba, et al.
Publicado: (2017) -
The association of pathergy reaction and active clinical presentations of Behçet’s disease
por: Assar, Shirin, et al.
Publicado: (2017) -
Streptococcal antigen in the pathogenesis of Behçet's disease
por: Kaneko, F, et al.
Publicado: (2003) -
Characterization of the major histocompatibility complex locus association with Behçet’s disease in Iran
por: Xavier, Joana M, et al.
Publicado: (2015)